Pleurodesis Using Hypertonic Glucose

Launched by LONDON HEALTH SCIENCES CENTRE RESEARCH INSTITUTE OR LAWSON RESEARCH INSTITUTE OF ST. JOSEPH'S · Mar 1, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at a treatment called pleurodesis using a solution of Dextrose, which is a type of sugar, to help fix air leaks from the lungs after surgery. Air leaks can happen when the lungs do not heal properly after surgeries to remove parts of the lung, and they can be quite common, affecting about 10% of patients who have major lung surgeries. The study aims to see if giving Dextrose directly into the chest area can help close these leaks and promote healing.

To participate in this trial, you must be an adult patient scheduled for surgery to remove part of your lung due to cancer and have a significant air leak that is measured on the first day after your surgery. The trial is not yet recruiting participants, but it is open to all genders, and there are no specific exclusion criteria. If you are eligible and choose to participate, you will receive the Dextrose treatment and be monitored to see how well it works in helping to close the air leak and support your recovery.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult patients undergoing scheduled pulmonary lobar or sublobar resection for cancer
• • Presence of air leak on postoperative day 1 of at least 100 mL/min, as documented on the digital drainage system
• Exclusion Criteria:
• • - None